United States Muscle Relaxants Market Report 2016

November 2016 | 103 pages | ID: UDD1FEE653AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Muscle Relaxants

Revenue, means the sales value of Muscle Relaxants

This report studies sales (consumption) of Muscle Relaxants in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• Claire Ellen Products, Inc. (US)
• Eli Lilly and Company (US)
• GlaxoSmithKline Plc (UK)
• Sanofi S.A (France)
• Meda AB (Sweden)
• Boehringer Ingelheim GmbH (Germany)
• Pierre Fabre Medicament (France)
• Cipla Limited (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Muscle Relaxants in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Muscle Relaxants Market Report 2016

1 MUSCLE RELAXANTS OVERVIEW

1.1 Product Overview and Scope of Muscle Relaxants
1.2 Classification of Muscle Relaxants
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Muscle Relaxants
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Muscle Relaxants (2011-2021)
  1.4.1 United States Muscle Relaxants Sales and Growth Rate (2011-2021)
  1.4.2 United States Muscle Relaxants Revenue and Growth Rate (2011-2021)

2 UNITED STATES MUSCLE RELAXANTS COMPETITION BY MANUFACTURERS

2.1 United States Muscle Relaxants Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Muscle Relaxants Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Muscle Relaxants Average Price by Manufactures (2015 and 2016)
2.4 Muscle Relaxants Market Competitive Situation and Trends
  2.4.1 Muscle Relaxants Market Concentration Rate
  2.4.2 Muscle Relaxants Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MUSCLE RELAXANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Muscle Relaxants Sales and Market Share by Type (2011-2016)
3.2 United States Muscle Relaxants Revenue and Market Share by Type (2011-2016)
3.3 United States Muscle Relaxants Price by Type (2011-2016)
3.4 United States Muscle Relaxants Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MUSCLE RELAXANTS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Muscle Relaxants Sales and Market Share by Application (2011-2016)
4.2 United States Muscle Relaxants Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MUSCLE RELAXANTS MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Muscle Relaxants Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Muscle Relaxants Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Claire Ellen Products, Inc. (US)
  5.3.2 Muscle Relaxants Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Claire Ellen Products, Inc. (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Muscle Relaxants Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 GlaxoSmithKline Plc (UK)
  5.5.2 Muscle Relaxants Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 GlaxoSmithKline Plc (UK) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Muscle Relaxants Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Meda AB (Sweden)
  5.7.2 Muscle Relaxants Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Meda AB (Sweden) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Boehringer Ingelheim GmbH (Germany)
  5.8.2 Muscle Relaxants Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Boehringer Ingelheim GmbH (Germany) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Pierre Fabre Medicament (France)
  5.9.2 Muscle Relaxants Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Pierre Fabre Medicament (France) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Cipla Limited (India)
  5.10.2 Muscle Relaxants Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Cipla Limited (India) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 MUSCLE RELAXANTS MANUFACTURING COST ANALYSIS

6.1 Muscle Relaxants Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Muscle Relaxants

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Muscle Relaxants Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Muscle Relaxants Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MUSCLE RELAXANTS MARKET FORECAST (2016-2021)

10.1 United States Muscle Relaxants Sales, Revenue Forecast (2016-2021)
10.2 United States Muscle Relaxants Sales Forecast by Type (2016-2021)
10.3 United States Muscle Relaxants Sales Forecast by Application (2016-2021)
10.4 Muscle Relaxants Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Muscle Relaxants
Table Classification of Muscle Relaxants
Figure United States Sales Market Share of Muscle Relaxants by Type in 2015
Table Application of Muscle Relaxants
Figure United States Sales Market Share of Muscle Relaxants by Application in 2015
Figure United States Muscle Relaxants Sales and Growth Rate (2011-2021)
Figure United States Muscle Relaxants Revenue and Growth Rate (2011-2021)
Table United States Muscle Relaxants Sales of Key Manufacturers (2015 and 2016)
Table United States Muscle Relaxants Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Muscle Relaxants Sales Share by Manufacturers
Figure 2016 Muscle Relaxants Sales Share by Manufacturers
Table United States Muscle Relaxants Revenue by Manufacturers (2015 and 2016)
Table United States Muscle Relaxants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Muscle Relaxants Revenue Share by Manufacturers
Table 2016 United States Muscle Relaxants Revenue Share by Manufacturers
Table United States Market Muscle Relaxants Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Muscle Relaxants Average Price of Key Manufacturers in 2015
Figure Muscle Relaxants Market Share of Top 3 Manufacturers
Figure Muscle Relaxants Market Share of Top 5 Manufacturers
Table United States Muscle Relaxants Sales by Type (2011-2016)
Table United States Muscle Relaxants Sales Share by Type (2011-2016)
Figure United States Muscle Relaxants Sales Market Share by Type in 2015
Table United States Muscle Relaxants Revenue and Market Share by Type (2011-2016)
Table United States Muscle Relaxants Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Muscle Relaxants by Type (2011-2016)
Table United States Muscle Relaxants Price by Type (2011-2016)
Figure United States Muscle Relaxants Sales Growth Rate by Type (2011-2016)
Table United States Muscle Relaxants Sales by Application (2011-2016)
Table United States Muscle Relaxants Sales Market Share by Application (2011-2016)
Figure United States Muscle Relaxants Sales Market Share by Application in 2015
Table United States Muscle Relaxants Sales Growth Rate by Application (2011-2016)
Figure United States Muscle Relaxants Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Muscle Relaxants Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Muscle Relaxants Sales Market Share (2011-2016)
Table Claire Ellen Products, Inc. (US) Basic Information List
Table Claire Ellen Products, Inc. (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Claire Ellen Products, Inc. (US) Muscle Relaxants Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Muscle Relaxants Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Muscle Relaxants Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Muscle Relaxants Sales Market Share (2011-2016)
Table Meda AB (Sweden) Basic Information List
Table Meda AB (Sweden) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meda AB (Sweden) Muscle Relaxants Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Muscle Relaxants Sales Market Share (2011-2016)
Table Pierre Fabre Medicament (France) Basic Information List
Table Pierre Fabre Medicament (France) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pierre Fabre Medicament (France) Muscle Relaxants Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Muscle Relaxants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Muscle Relaxants Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Muscle Relaxants
Figure Manufacturing Process Analysis of Muscle Relaxants
Figure Muscle Relaxants Industrial Chain Analysis
Table Raw Materials Sources of Muscle Relaxants Major Manufacturers in 2015
Table Major Buyers of Muscle Relaxants
Table Distributors/Traders List
Figure United States Muscle Relaxants Production and Growth Rate Forecast (2016-2021)
Figure United States Muscle Relaxants Revenue and Growth Rate Forecast (2016-2021)
Table United States Muscle Relaxants Production Forecast by Type (2016-2021)
Table United States Muscle Relaxants Consumption Forecast by Application (2016-2021)